A protein called ADAR may help glioblastoma cells move
Original title: Targeting ADAR stability: a novel approach to combat glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in lab cells and computer data, not in people.
The short version
In lab tests, a protein called ADAR made brain tumor cells move more.
What was studied. Scientists looked at a protein called ADAR across many cancer types using large gene databases. They then tested it in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells grown in a dish.
What they found. ADAR levels were high in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, mostly in the tumor cells themselves. In lab tests, ADAR made the tumor cells move more. The team also found a second protein, STUB1, that breaks ADAR down. When they lowered STUB1, ADAR levels went up and the cells moved more.
What this means, and what it doesn't
What it could mean: This gives scientists a new target to study for future glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary drugs. It also helps explain how these tumor cells may spread.
What it doesn't mean: This is not a treatment, and it is not a cure. The work was done in cells in a dish and in gene databases, not in people. No one has tested whether changing these proteins helps patients. This is very early science and is a long way from the care a doctor can give today.
Source: PubMed, August 6, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.